Related Experiment Video
Updated: May 13, 2026
Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in
1Department of Pharmacology, Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China, 150081. a.z.hrbmu@gmail.com
Abstract:
Previous studies have demonstrated that chronic brain hypoperfusion (CBH) causes Aβ aggregation by upregulating expression of amyloid precursor protein (APP) and β-site APP cleaving enzyme 1 (BACE1) protein, which is accompanied by cognitive impairment, but the mechanisms are not fully understood. In this study, we evaluated the effect of microRNA on memory impairment in rats induced by CBH. We show here that CBH generated by bilateral common carotid artery occlusion (2VO) significantly decreased the learning and memory ability in rats, as assessed by Morris water maze, and upregulated expression of APP and BACE1 proteins in the hippocampus and cortex of rats, as evaluated by Western blot and immunofluorescence. In reciprocal, qRT-PCR analysis showed that microRNA-195 (miR-195) was downregulated in both the hippocampus and cortex of rats following CBH, and in the plasma of dementia patients. APP and BACE1 proteins were downregulated by miR-195 overexpression, upregulated by miR-195 inhibition, and unchanged by binding-site mutation or miR-masks, indicating that APP and BACE1 are two potential targets for miR-195. Knockdown of endogenous miR-195 by lentiviral vector-mediated overexpression of its antisense molecule (lenti-pre-AMO-miR-195) elicited dementia in rats, whereas overexpression of miR-195 using lenti-pre-miR-195 reduced dementia vulnerability triggered by 2VO. Additionally, chromatin immunoprecipitation analysis showed that NFκB was bound to the promoter region of miR-195 and inhibited its expression. We conclude that miR-195 may play a key role in determining dementia susceptibility in 2VO rats by regulating APP and BACE1 expression at the post-transcriptional level, and exogenous complement of miR-195 may be a potentially valuable anti-dementia approach.
Insights
Chronic brain hypoperfusion (CBH) impairs memory by altering amyloid precursor protein (APP) and BACE1. MicroRNA-195 (miR-195) levels decrease, suggesting it
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Chronic brain hypoperfusion (CBH) is linked to cognitive impairment and increased amyloid precursor protein (APP) and β-site APP cleaving enzyme 1 (BACE1) expression.
- The precise molecular mechanisms underlying CBH-induced cognitive decline remain incompletely understood.
Purpose of the Study:
- To investigate the role of microRNA in memory deficits associated with CBH.
- To identify specific microRNAs and their targets involved in the pathogenesis of CBH-induced dementia.
Main Methods:
- Induction of CBH in rats via bilateral common carotid artery occlusion (2VO).
- Assessment of learning and memory using the Morris water maze.
- Quantification of APP and BACE1 protein levels via Western blot and immunofluorescence.
- Analysis of microRNA-195 (miR-195) expression using qRT-PCR.
- Investigating miR-195's regulatory effects on APP and BACE1 through overexpression and inhibition studies.
- Utilizing lentiviral vectors for in vivo manipulation of miR-195 levels.
- Chromatin immunoprecipitation to assess NFκB binding to the miR-195 promoter.
Main Results:
- 2VO significantly impaired learning and memory in rats and upregulated hippocampal and cortical APP and BACE1.
- miR-195 was downregulated in the brain and plasma of rats with CBH and in dementia patients.
- miR-195 directly targets and downregulates APP and BACE1.
- Inhibition of endogenous miR-195 exacerbated dementia symptoms, while miR-195 overexpression ameliorated them.
- NFκB was identified as a repressor of miR-195 expression.
Conclusions:
- miR-195 plays a critical role in modulating dementia susceptibility in the context of CBH by regulating APP and BACE1 at the post-transcriptional level.
- Restoring miR-195 levels represents a potential therapeutic strategy for dementia associated with CBH.
